Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.1K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

4.7K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.7K
Principles of Drug Action01:24

Principles of Drug Action

5.6K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.6K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

429
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
429
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

254
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
254
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

377
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
377

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

TraNce: Type-aware hypergraph neural network with biological mediators for drug repositioning.

Neural networks : the official journal of the International Neural Network Society·2026
Same author

Pelvic schwannoma misdiagnosed as colorectal cancer metastasis and the corresponding diagnostic lessons: A report of two cases.

Oncology letters·2026
Same author

Debiased medication recommendation through fusing frequent pattern and temporal medical records.

Neural networks : the official journal of the International Neural Network Society·2026
Same author

Synthesis of one-dimensional silver nanowires in aqueous solution using phloroglucinol as a reducing reagent.

Dalton transactions (Cambridge, England : 2003)·2026
Same author

Transcriptomic and single-cell analyses reveal the prognostic value of ETV4 and its role in shaping the immune landscape of colorectal cancer.

Translational oncology·2026
Same author

Multi-modal contrastive learning based on molecular and textual data for drug response prediction.

Neural networks : the official journal of the International Neural Network Society·2026

相关实验视频

Updated: May 6, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

基于知识和关系意识的协同学习,用于药物重新定位.

Shilong Wang, Yuanxin Liu, Xiaobo Li

    IEEE journal of biomedical and health informatics
    |April 29, 2025
    PubMed
    概括

    克兰通过改进药物发现的知识图分析来增强药物重新定位. 这种关系意识方法更好地捕捉了药物疾病相互作用,并克服了训练中的噪音,以实现更稳定的优化.

    科学领域:

    • 药理学和药物发现
    • 生物信息学和计算生物学
    • 人工智能在医学中的应用

    背景情况:

    • 药物重新定位通过确定现有药物的新用途来加速药物发现.
    • 目前的知识图 (KG) 方法与复杂的药物-疾病关系和协同作用机制作斗争.
    • 图形神经网络 (GNN) 和知识图嵌入 (KGE) 方法面临着噪音和不稳定的优化挑战.

    研究的目的:

    • 引入KRANE,一种基于知识和关系意识的协同学习方法,用于药物重新定位.
    • 解决目前基于KG的药物重新定位方法的局限性,特别是捕捉复杂的关系和协同效应.
    • 通过在训练期间减轻噪音来提高药物重新定位模型的稳定性和准确性.

    主要方法:

    • 开发了一个关系感知特征提取器 (RAFE),使用上下文三倍注意力得分来增强复杂的关系特征的表示.
    • 实施了协同特征重建模块,以提取药物和疾病之间的协同异质特征相互作用.
    • 提出了知识调节损失函数,以尽量减少噪声对模型训练的影响,并优化性能.

    主要成果:

    • 在三个公共数据集中,KRANE显示了与现有的药物重新定位方法相比的显著改进.
    • 关系意识的方法有效地捕获了复杂的药物-药物,药物-疾病和疾病-疾病的关系.

    更多相关视频

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    11.5K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    21.0K

    相关实验视频

    Last Updated: May 6, 2026

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    9.6K
    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    11.5K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    21.0K
  • 协同的特征提取成功地确定了药物和疾病之间的未被探索的机制.
  • 结论:

    • 克兰通过增强知识图分析,为药物重新定位提供了一种有效和强大的方法.
    • 该方法成功地解决了药物发现现有GNN和KGE技术的局限性.
    • 克兰为确定现有药物的新治疗途径提供了一个稳定而准确的框架.